Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Brigham and Women's Hospital, Inc. et al v. Perrigo Company et al
Case Number:
1:13-cv-11640
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 18, 2017
$10M Pepcid Patent Verdict Nixed As Judge Reverses Herself
Perrigo Co. has not infringed various aspects of a Boston hospital's now-expired patent on the Pepcid Complete antacid, a Massachusetts federal judge said Friday, reversing the findings in three of her previous judgments and negating a $10.2 million jury verdict.
-
August 02, 2017
Perrigo Gets A Mulligan On $10M IP Verdict Appeal
A flurry of rulings Wednesday over a $10.2 million patent infringement verdict against Perrigo, including one by the Federal Circuit, mean that a district judge's December entry of judgment was not technically final and that Perrigo will get a chance to appeal after initially missing a 30-day window.
-
February 16, 2017
Hospital Slams Bids To Ax $10M Pepcid Patent Verdict
A Boston hospital argued Wednesday that attempts by over-the-counter drug maker Perrigo Co. to overturn a $10.2 million Pepcid patent infringement verdict ignored the evidence presented to the jury.
-
January 25, 2017
Perrigo Seeks New Trial After $10M Patent Verdict
Perrigo Co. on Tuesday fought back against the $10.2 million jury verdict it is facing for infringing a Boston hospital's now-expired patent for the Pepcid Complete antacid, filing a flurry of motions seeking a new trial, a lesser judgement and various other favorable judgments.
-
January 23, 2017
Hospital Wants To Triple $10M Jury Verdict Over Pepcid Patent
A Boston hospital on Friday asked a Massachusetts federal judge to triple the $10.2 million jury award it won last month on claims that drugmaker Perrigo's generic version of Pepcid Complete antacid infringed on its now-expired patent, saying the pharmaceutical company engaged in "egregious" misconduct.
-
December 15, 2016
Jury Finds Perrigo Infringed Pepcid Patent, Must Pay $10M
A Massachusetts federal jury found Wednesday that pharmaceutical maker Perrigo's generic version of Pepcid Complete antacid infringed a Boston hospital's now-expired patent and awarded the hospital $10.2 million in royalty damages.